VC firm
Everbright Biofund
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Taipei, Taiwan
Claim, correct or request removal
Record updated 17 September 2026
About
Yongming Biotech was initiated by the Biotech Strategy Center. Combining resources from the technology and finance sectors, it provides key funding to biomedical startup teams with international potential, strengthening their capital, accelerating R&D and expanding into global markets, so as to achieve corporate growth and create long-term value.
Investment approach
- Thesis
- Focused on MedTech, BioTech and HealthTech, covering high-potential innovations such as medical technology, new drugs, cell therapy, digital health and precision health.Source (opens in a new tab)
- Investing status notes
- 永續型創業投資公司
Locations
- Headquarters
- 台北市, Taiwan
Loading relationship preview